XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Statement of Comprehensive Income [Abstract]        
Net loss $ (37,383) $ (6,927) $ (48,235) $ (20,672)
Available for sale securities - net unrealized gain (loss) 5 (47) 5 (51)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (25) 0 (25) 0
Total other comprehensive loss (20) (47) (20) (51)
Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders $ (37,403) $ (6,974) $ (48,255) $ (20,723)